Literature DB >> 34902573

Sugars and Gastrointestinal Health.

Djésia Arnone1, Caroline Chabot2, Anne-Charlotte Heba3, Tunay Kökten3, Bénédicte Caron4, Franck Hansmannel3, Natacha Dreumont3, Ashwin N Ananthakrishnan5, Didier Quilliot6, Laurent Peyrin-Biroulet7.   

Abstract

Sugar overconsumption is linked to a rise in the incidence of noncommunicable diseases such as diabetes, cardiovascular diseases, and cancer. This increased incidence is becoming a real public health problem that is more severe than infectious diseases, contributing to 35 million deaths annually. Excessive intake of free sugars can cause many of the same health problems as excessive alcohol consumption. Many recent international recommendations have expressed concerns about sugar consumption in Westernized societies, as current consumption levels represent quantities with no precedent during hominin evolution. In both adults and children, the World Health Organization strongly recommends reducing free sugar intake to <10% of total energy intake and suggests a further reduction to below 5%. Most studies have focused on the deleterious effects of Western dietary patterns on global health and the intestine. Whereas excessive dietary fat consumption is well studied, the specific impact of sugar is poorly described, while refined sugars represent up to 40% of caloric intake within industrialized countries. However, high sugar intake is associated with multiple tissue and organ dysfunctions. Both hyperglycemia and excessive sugar intake disrupt the intestinal barrier, thus increasing gut permeability and causing profound gut microbiota dysbiosis, which results in a disturbance in mucosal immunity that enhances infection susceptibility. This review aims to highlight the roles of different types of dietary carbohydrates and the consequences of their excessive intake for intestinal homeostasis.
Copyright © 2022 AGA Institute. All rights reserved.

Entities:  

Keywords:  Carbohydrates; Fructose; Glucose; Gut Microbiota; Intestine; Nutrition; Sugars

Mesh:

Substances:

Year:  2021        PMID: 34902573     DOI: 10.1016/j.cgh.2021.12.011

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   13.576


  2 in total

Review 1.  Anti-Hyperglycemic Agents in the Adjuvant Treatment of Sepsis: Improving Intestinal Barrier Function.

Authors:  Yi-Feng Wang; Jia-Wei Li; Da-Peng Wang; Ke Jin; Jiao-Jie Hui; Hong-Yang Xu
Journal:  Drug Des Devel Ther       Date:  2022-06-04       Impact factor: 4.319

2.  Sensitive Non-Enzymatic Glucose Electrochemical Sensor Based on Electrochemically Synthesized PANI/Bimetallic Oxide Composite.

Authors:  Anish Khan; Aftab Aslam Parwaz Khan; Hadi M Marwani; Maha Moteb Alotaibi; Abdullah M Asiri; Ayyar Manikandan; Suchart Siengchin; Sanjay Mavinkere Rangappa
Journal:  Polymers (Basel)       Date:  2022-07-27       Impact factor: 4.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.